Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Mueller

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|September 2, 1998
Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need ProgramE A Mueller, J M Kovarik, D Pittrow
Journal of Immunological Methods|May 25, 1990
Preservation of cytotoxic function during multi-cycle immunomagnetic cell separations of human NK cells using a new type of magnetic beadE Pflueger, E A Mueller, F A Anderer
Transplantation Proceedings|October 1, 1994
Minor influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporineE A Mueller, J M Kovarik, K Kutz
Journal of Molecular and Cellular Cardiology|July 1, 1977
Isoproterenol-induced cardiomyopathy: changes in cardiac enzymes and protection by methylprednisoloneE A Mueller, W S Griffin, K Wildenthal
Therapeutic Drug Monitoring|August 1, 1996
Clinical development of a cyclosporine microemulsion in transplantationJ M Kovarik, E A Mueller, D Niese
Psychopharmacology|January 1, 1986
Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humansE A Mueller, D L Murphy, T Sunderland
Immunopharmacology|January 1, 1989
Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicityE A Mueller, K Hamprecht, F A Anderer
The Journal of Clinical Endocrinology and Metabolism|December 1, 1985
Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humansE A Mueller, D L Murphy, T Sunderland
Deutsche Medizinische Wochenschrift (1946)|March 25, 2005
[Innovation instead of imitation -- news in drug therapy]E A Mueller, P Bramlage, W Böcking, et al.
Journal of Clinical Pharmacology|March 20, 1998
Optimizing the absorption of valspodar, a P-glycoprotein modulator, Part II: Quantifying its pharmacokinetic variability and refining the bioavailability estimateJ M Kovarik, E A Mueller, F Richard, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|September 2, 1998
Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need ProgramE A Mueller, J M Kovarik, D Pittrow
Journal of Immunological Methods|May 25, 1990
Preservation of cytotoxic function during multi-cycle immunomagnetic cell separations of human NK cells using a new type of magnetic beadE Pflueger, E A Mueller, F A Anderer
Transplantation Proceedings|October 1, 1994
Minor influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporineE A Mueller, J M Kovarik, K Kutz
Journal of Molecular and Cellular Cardiology|July 1, 1977
Isoproterenol-induced cardiomyopathy: changes in cardiac enzymes and protection by methylprednisoloneE A Mueller, W S Griffin, K Wildenthal
Therapeutic Drug Monitoring|August 1, 1996
Clinical development of a cyclosporine microemulsion in transplantationJ M Kovarik, E A Mueller, D Niese
Psychopharmacology|January 1, 1986
Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humansE A Mueller, D L Murphy, T Sunderland
Immunopharmacology|January 1, 1989
Biochemical characterization of a component in extracts of Viscum album enhancing human NK cytotoxicityE A Mueller, K Hamprecht, F A Anderer
The Journal of Clinical Endocrinology and Metabolism|December 1, 1985
Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humansE A Mueller, D L Murphy, T Sunderland
Deutsche Medizinische Wochenschrift (1946)|March 25, 2005
[Innovation instead of imitation -- news in drug therapy]E A Mueller, P Bramlage, W Böcking, et al.
Journal of Clinical Pharmacology|March 20, 1998
Optimizing the absorption of valspodar, a P-glycoprotein modulator, Part II: Quantifying its pharmacokinetic variability and refining the bioavailability estimateJ M Kovarik, E A Mueller, F Richard, et al.
Pageof 10